PVRIG Antibody (969102) [Alexa Fluor® 647]

• Reactivity: Hu, Mu
• Applications: WB, ICC/IF
• Clone: 969102
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 647

PVRIG Antibody (969102) [Alexa Fluor® 647] Summary

• Immunogen: Human PVRIG synthtic peptide
  Accession # Q6DKI7
• Specificity: Detects human and mouse PVRIG in Western blots.
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Immunocytochemistry
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for PVRIG Antibody (969102) [Alexa Fluor® 647]

• C7orf15
• C7orf15MGC138295
• CD112R
• MGC104322
• MGC138297
• MGC2463
• poliovirus receptor related immunoglobulin domain containing
• Poliovirus receptor-related immunoglobulin domain-containing protein
• PVRIG
• transmembrane protein PVRIG

Background

Human PVRIG (poliovirus receptor related immunoglobulin domain-containing protein), also known as CD112 receptor (CD112R), is an approximately 34 kDa single transmembrane protein in the poliovirus receptor-like protein (PVR) family (1). It is composed of a single extracellular IgV domain, one transmembrane domain, and a long intracellular domain. The intracellular domain contains two tyrosine residues, one within an ITIM-like motif that is a potential docking site for phosphatases (1). The extracellular domain sequence of human and mouse PVRIG have approximately 65% similarity. The human PVRIG gene is preferentially expressed in lymphocytes, such as T cells and NK cells, but not in monocyte derived dendritic cells (1). PVRIG functions as a cell surface receptor for Nectin-2/CD112, a cell surface protein that is widely expressed on antigen-presenting cells and tumor cells. Disrupting the PVRIG/Nectin-2 interaction enhances human T cell response, suggesting PVRIG is a novel checkpoint for human T cells (1).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.